Adaptimmune stock plunges after announcing Nasdaq delisting plans
GOLDEN, Colo. & MONTREAL - Molson Coors Beverage Company (NYSE:TAP, TAP.A) announced Wednesday it will pay a quarterly dividend of $0.47 per share on its Class A and Class B common stock on September 19, 2025, to stockholders of record as of September 5, 2025.
The company’s Canadian subsidiary, Molson Coors Canada Inc. (TSX:TPX.B, TPX.A), also declared a quarterly dividend of approximately CAD$0.64 per share for its Class A and Class B exchangeable shareholders, payable on the same date to shareholders of record on September 5. The Canadian dividends are eligible dividends for Canadian tax purposes. With the stock currently trading near its 52-week low and showing signs of undervaluation based on InvestingPro’s Fair Value analysis, investors seeking detailed dividend sustainability metrics and 12 additional exclusive ProTips can explore the comprehensive Pro Research Report available on InvestingPro.
Molson Coors Beverage Company, with a history spanning more than two centuries, produces a portfolio of beverages that includes core brands such as Coors Light, Miller Lite, and Molson Canadian, as well as premium offerings and products beyond the beer category.
The dividend announcement was made in a company press release.
In other recent news, Molson Coors has faced several adjustments in analyst ratings and price targets due to ongoing challenges in the beer industry. UBS has reduced its price target for the company to $59 from $63, following a first-quarter earnings per share (EPS) report of $0.50, which fell short of both UBS’s estimate and the Visible Alpha consensus. The company has also revised its full-year guidance downward, citing macroeconomic pressures and declining U.S. volumes. Piper Sandler has similarly lowered its price target to $53, noting a 5% year-to-date decline in U.S. retail volumes and rising aluminum costs affecting the company. BofA Securities downgraded Molson Coors from Buy to Neutral, reducing the price target to $50, highlighting persistent volume declines in the beer industry. Citi has also adjusted its price target to $51, attributing the change to ongoing volume pressures and the termination of certain contract brewing arrangements. Despite these challenges, Molson Coors has secured exclusive U.S. commercialization rights for Fever-Tree, which is expected to partially offset volume declines. These developments reflect a complex environment for Molson Coors as it navigates industry and economic headwinds.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.